BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Francavilla R, Lionetti E, Castellaneta SP, Magistà AM, Maurogiovanni G, Bucci N, De Canio A, Indrio F, Cavallo L, Ierardi E. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study. Helicobacter. 2008;13:127-134. [PMID: 18321302 DOI: 10.1111/j.1523-5378.2008.00593.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 68] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Fang HR, Zhang GQ, Cheng JY, Li ZY. Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials.Eur J Pediatr. 2019;178:7-16. [PMID: 30446816 DOI: 10.1007/s00431-018-3282-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 8.7] [Reference Citation Analysis]
2 Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, Johnston BC. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12:CD006095. [PMID: 29257353 DOI: 10.1002/14651858.cd006095.pub4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 19.5] [Reference Citation Analysis]
3 Nair MR, Chouhan D, Sen Gupta S, Chattopadhyay S. Fermented Foods: Are They Tasty Medicines for Helicobacter pylori Associated Peptic Ulcer and Gastric Cancer? Front Microbiol 2016;7:1148. [PMID: 27504109 DOI: 10.3389/fmicb.2016.01148] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
4 Osaki T, Matsuki T, Asahara T, Zaman C, Hanawa T, Yonezawa H, Kurata S, Woo TD, Nomoto K, Kamiya S. Comparative analysis of gastric bacterial microbiota in Mongolian gerbils after long-term infection with Helicobacter pylori. Microb Pathog. 2012;53:12-18. [PMID: 22783557 DOI: 10.1016/j.micpath.2012.03.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
5 Ierardi E, Giorgio F, Losurdo G, Di Leo A, Principi M. How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography? World J Gastroenterol. 2013;19:8168-8180. [PMID: 24363506 DOI: 10.3748] [Reference Citation Analysis]
6 Lionetti E, Indrio F, Pavone L, Borrelli G, Cavallo L, Francavilla R. Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature. Helicobacter. 2010;15:79-87. [PMID: 20402810 DOI: 10.1111/j.1523-5378.2009.00743.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
7 Boltin D. Probiotics in Helicobacter pylori-induced peptic ulcer disease. Best Pract Res Clin Gastroenterol. 2016;30:99-109. [PMID: 27048901 DOI: 10.1016/j.bpg.2015.12.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
8 Orlando A, Refolo MG, Messa C, Amati L, Lavermicocca P, Guerra V, Russo F. Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines. Nutr Cancer 2012;64:1103-11. [PMID: 23061912 DOI: 10.1080/01635581.2012.717676] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 8.0] [Reference Citation Analysis]
9 Zhang MM, Qian W, Qin YY, He J, Zhou YH. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis. World J Gastroenterol. 2015;21:4345-4357. [PMID: 25892886 DOI: 10.3748/wjg.v21.i14.4345] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 52] [Article Influence: 14.6] [Reference Citation Analysis]
10 Dore MP, Bibbò S, Pes GM, Francavilla R, Graham DY. Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor. Can J Infect Dis Med Microbiol 2019;2019:3409820. [PMID: 31065301 DOI: 10.1155/2019/3409820] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Emara MH, Elhawari SA, Yousef S, Radwan MI, Abdel-Aziz HR. Emerging Role of Probiotics in the Management of Helicobacter pylori Infection: Histopathologic Perspectives. Helicobacter 2016;21:3-10. [PMID: 25997615 DOI: 10.1111/hel.12237] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
12 Zhu XY, Liu F. Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy. J Dig Dis. 2017;18:195-202. [PMID: 28294543 DOI: 10.1111/1751-2980.12466] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Zou J, Dong J, Yu X. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter. 2009;14:97-107. [PMID: 19751434 DOI: 10.1111/j.1523-5378.2009.00716.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
14 Puebla-Barragan S, Reid G. Forty-five-year evolution of probiotic therapy. Microb Cell 2019;6:184-96. [PMID: 30956971 DOI: 10.15698/mic2019.04.673] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
15 Dore MP, Goni E, Di Mario F. Is There a Role for Probiotics in Helicobacter pylori Therapy? Gastroenterol Clin North Am 2015;44:565-75. [PMID: 26314668 DOI: 10.1016/j.gtc.2015.05.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
16 Goli YD, Moniri R. Efficacy of probiotics as an adjuvant agent in eradication of Helicobacter pylori infection and associated side effects. Beneficial Microbes 2016;7:519-27. [DOI: 10.3920/bm2015.0130] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Yang Y, Tian J, Yang B. Targeting gut microbiome: A novel and potential therapy for autism.Life Sci. 2018;194:111-119. [PMID: 29277311 DOI: 10.1016/j.lfs.2017.12.027] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 12.0] [Reference Citation Analysis]
18 Pop OL, Vodnar DC, Diaconeasa Z, Istrati M, Bințințan A, Bințințan VV, Suharoschi R, Gabbianelli R. An Overview of Gut Microbiota and Colon Diseases with a Focus on Adenomatous Colon Polyps. Int J Mol Sci 2020;21:E7359. [PMID: 33028024 DOI: 10.3390/ijms21197359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Patel A, Shah N, Prajapati JB. Clinical application of probiotics in the treatment of Helicobacter pylori infection--a brief review. J Microbiol Immunol Infect. 2014;47:429-437. [PMID: 23757373 DOI: 10.1016/j.jmii.2013.03.010] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
20 Rattanaprasert M, Roos S, Hutkins RW, Walter J. Quantitative evaluation of synbiotic strategies to improve persistence and metabolic activity of Lactobacillus reuteri DSM 17938 in the human gastrointestinal tract. Journal of Functional Foods 2014;10:85-94. [DOI: 10.1016/j.jff.2014.05.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
21 Qureshi N, Li P, Gu Q. Probiotic therapy in Helicobacter pylori infection: a potential strategy against a serious pathogen? Appl Microbiol Biotechnol 2019;103:1573-88. [PMID: 30610283 DOI: 10.1007/s00253-018-09580-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
22 Iannitti T, Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr 2010;29:701-25. [PMID: 20576332 DOI: 10.1016/j.clnu.2010.05.004] [Cited by in Crossref: 137] [Cited by in F6Publishing: 92] [Article Influence: 12.5] [Reference Citation Analysis]
23 Wolvers D, Antoine JM, Myllyluoma E, Schrezenmeir J, Szajewska H, Rijkers GT. Guidance for substantiating the evidence for beneficial effects of probiotics: Prevention and management of infections by probiotics. J Nutr. 2010;140:698S-712S. [PMID: 20107143 DOI: 10.3945/jn.109.113753] [Cited by in Crossref: 101] [Cited by in F6Publishing: 81] [Article Influence: 9.2] [Reference Citation Analysis]
24 Yu M, Zhang R, Ni P, Chen S, Duan G. Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials. PLoS One 2019;14:e0223309. [PMID: 31577828 DOI: 10.1371/journal.pone.0223309] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
25 Zhang M. High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment. World J Gastroenterol. 2015;21:13432-13437. [PMID: 26730153 DOI: 10.3748/wjg.v21.i48.13432] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 23] [Article Influence: 6.4] [Reference Citation Analysis]
26 Liévin-Le Moal V, Servin AL. Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clin Microbiol Rev 2014;27:167-99. [PMID: 24696432 DOI: 10.1128/CMR.00080-13] [Cited by in Crossref: 177] [Cited by in F6Publishing: 80] [Article Influence: 35.4] [Reference Citation Analysis]
27 Asgari B, Kermanian F, Hedayat Yaghoobi M, Vaezi A, Soleimanifar F, Yaslianifard S. The Anti-Helicobacter pylori Effects of Lactobacillus acidophilus, L. plantarum, and L. rhamnosus in Stomach Tissue of C57BL/6 Mice. Visc Med 2020;36:137-43. [PMID: 32356850 DOI: 10.1159/000500616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Safavi M, Sabourian R, Foroumadi A. Treatment of Helicobacter pylori infection: Current and future insights. World J Clin Cases. 2016;4:5-19. [PMID: 26798626 DOI: 10.12998/wjcc.v4.i1.5] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 33] [Article Influence: 12.4] [Reference Citation Analysis]
29 Diez-Echave P, Martín-Cabrejas I, Garrido-Mesa J, Langa S, Vezza T, Landete JM, Hidalgo-García L, Algieri F, Mayer MJ, Narbad A, García-Lafuente A, Medina M, Rodríguez-Nogales A, Rodríguez-Cabezas ME, Gálvez J, Arqués JL. Probiotic and Functional Properties of Limosilactobacillus reuteri INIA P572. Nutrients 2021;13:1860. [PMID: 34072532 DOI: 10.3390/nu13061860] [Reference Citation Analysis]
30 Ji J, Yang H. Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy.Int J Mol Sci. 2020;21. [PMID: 32046317 DOI: 10.3390/ijms21031136] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
31 Hsieh MH, Versalovic J. The human microbiome and probiotics: implications for pediatrics. Curr Probl Pediatr Adolesc Health Care 2008;38:309-27. [PMID: 18992706 DOI: 10.1016/j.cppeds.2008.09.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
32 Hsieh PS, Tsai YC, Chen YC, Teh SF, Ou CM, King VA. Eradication of Helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32. Helicobacter. 2012;17:466-477. [PMID: 23067294 DOI: 10.1111/j.1523-5378.2012.00992.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
33 Francavilla R, Lionetti E, Castellaneta S, Ciruzzi F, Indrio F, Masciale A, Fontana C, La Rosa MM, Cavallo L, Francavilla A. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea--a double-blind study. Aliment Pharmacol Ther 2012;36:363-9. [PMID: 22680836 DOI: 10.1111/j.1365-2036.2012.05180.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
34 Du YQ, Su T, Fan JG, Lu YX, Zheng P, Li XH, Guo CY, Xu P, Gong YF, Li ZS. Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection. World J Gastroenterol. 2012;18:6302-6307. [PMID: 23180952 DOI: 10.3748/wjg.v18.i43.6302] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
35 Homan M, Orel R. Are probiotics useful in Helicobacter pylori eradication? World J Gastroenterol. 2015;21:10644-10653. [PMID: 26457024 DOI: 10.3748/wjg.v21.i37.10644] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
36 Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in Human Health and Diseases. Front Microbiol. 2018;9:757. [PMID: 29725324 DOI: 10.3389/fmicb.2018.00757] [Cited by in Crossref: 135] [Cited by in F6Publishing: 97] [Article Influence: 45.0] [Reference Citation Analysis]
37 Hoy-Schulz YE, Jannat K, Roberts T, Zaidi SH, Unicomb L, Luby S, Parsonnet J. Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial. BMC Complement Altern Med 2016;16:44. [PMID: 26832746 DOI: 10.1186/s12906-016-1016-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
38 Park JM, Lee WH, Seo H, Oh JY, Lee DY, Kim SJ, Hahm KB. Microbiota changes with fermented kimchi contributed to either the amelioration or rejuvenation of Helicobacter pylori-associated chronic atrophic gastritis. J Clin Biochem Nutr 2021;69:98-110. [PMID: 34376919 DOI: 10.3164/jcbn.20-123] [Reference Citation Analysis]
39 Ojetti V, Bruno G, Ainora ME, Gigante G, Rizzo G, Roccarina D, Gasbarrini A. Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy. Gastroenterol Res Pract. 2012;2012:740381. [PMID: 22690211 DOI: 10.1155/2012/740381] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
40 Ierardi E, Giorgio F, Losurdo G, Di Leo A, Principi M. How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography? World J Gastroenterol. 2013;19:8168-8180. [PMID: 24363506 DOI: 10.3748/wjg.v19.i45.8168] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 60] [Article Influence: 8.9] [Reference Citation Analysis]
41 Stevens M, Vollenweider S, Lacroix C, Zurich E. The potential of reuterin produced by Lactobacillus reuteri as a broad spectrum preservative in food. Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Elsevier; 2011. pp. 129-60. [DOI: 10.1533/9780857090522.1.129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Emara MH, Mohamed SY, Abdel-Aziz HR. Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial. Therap Adv Gastroenterol. 2014;7:4-13. [PMID: 24381643 DOI: 10.1177/1756283x13503514] [Cited by in Crossref: 38] [Cited by in F6Publishing: 11] [Article Influence: 5.4] [Reference Citation Analysis]
43 Goldenberg JZ, Ma SS, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, Guyatt GH, Johnston BC. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095. [PMID: 23728658 DOI: 10.1002/14651858.cd006095.pub3] [Cited by in Crossref: 86] [Cited by in F6Publishing: 96] [Article Influence: 10.8] [Reference Citation Analysis]
44 Holz C, Busjahn A, Mehling H, Arya S, Boettner M, Habibi H, Lang C. Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study. Probiotics Antimicrob Proteins. 2015;7:91-100. [PMID: 25481036 DOI: 10.1007/s12602-014-9181-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
45 Orlando A, Messa C, Linsalata M, Cavallini A, Russo F. Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines. Immunopharmacol Immunotoxicol 2009;31:108-16. [PMID: 19234959 DOI: 10.1080/08923970802443631] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
46 Mehling H, Busjahn A. Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans. Nutrients 2013;5:3062-73. [PMID: 23917169 DOI: 10.3390/nu5083062] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
47 Gasparetto M, Pescarin M, Guariso G. Helicobacter pylori Eradication Therapy: Current Availabilities. ISRN Gastroenterol. 2012;2012:186734. [PMID: 22900197 DOI: 10.5402/2012/186734] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
48 Vítor JM, Vale FF. Alternative therapies for Helicobacter pylori: probiotics and phytomedicine. FEMS Immunol Med Microbiol. 2011;63:153-164. [PMID: 22077218 DOI: 10.1111/j.1574-695x.2011.00865.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 32] [Article Influence: 6.9] [Reference Citation Analysis]
49 Poonyam P, Chotivitayatarakorn P, Vilaichone RK. High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study. Asian Pac J Cancer Prev 2019;20:2859-64. [PMID: 31554388 DOI: 10.31557/APJCP.2019.20.9.2859] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
50 Delgado S, Leite AM, Ruas-Madiedo P, Mayo B. Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis. Front Microbiol 2014;5:766. [PMID: 25642213 DOI: 10.3389/fmicb.2014.00766] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 5.7] [Reference Citation Analysis]
51 Medeiros JA, Pereira MI. The use of probiotics in Helicobacter pylori eradication therapy. J Clin Gastroenterol. 2013;47:1-5. [PMID: 23222208 DOI: 10.1097/mcg.0b013e3182702dbc] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
52 Dargenio C, Dargenio VN, Bizzoco F, Indrio F, Francavilla R, Cristofori F. Limosilactobacillus reuteri Strains as Adjuvants in the Management of Helicobacter pylori Infection. Medicina (Kaunas) 2021;57:733. [PMID: 34357014 DOI: 10.3390/medicina57070733] [Reference Citation Analysis]
53 Tongtawee T, Dechsukhum C, Leeanansaksiri W, Kaewpitoon S, Kaewpitoon N, Loyd RA, Matrakool L, Panpimanmas S. Improved Helicobacter pylori Eradication Rate of Tailored Triple Therapy by Adding Lactobacillus delbrueckii and Streptococcus thermophilus in Northeast Region of Thailand: A Prospective Randomized Controlled Clinical Trial. Gastroenterol Res Pract. 2015;2015:518018. [PMID: 26167176 DOI: 10.1155/2015/518018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
54 Zhang S, Shi D, Li M, Li Y, Wang X, Li W. The relationship between gastric microbiota and gastric disease. Scand J Gastroenterol 2019;54:391-6. [PMID: 30945954 DOI: 10.1080/00365521.2019.1591499] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
55 De Vuyst L, Vincent P, Makras E, Leroy F, Pot B. Peptide Extracts from Cultures of Certain Lactobacilli Inhibit Helicobacter pylori. Probiotics & Antimicro Prot 2010;2:26-36. [DOI: 10.1007/s12602-009-9029-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
56 Dang Y, Reinhardt JD, Zhou X, Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis. PLoS One. 2014;9:e111030. [PMID: 25365320 DOI: 10.1371/journal.pone.0111030] [Cited by in Crossref: 78] [Cited by in F6Publishing: 55] [Article Influence: 11.1] [Reference Citation Analysis]
57 Efrati C, Nicolini G, Cannaviello C, O’Sed NP, Valabrega S. Helicobacter pylori eradication: sequential therapy and Lactobacillus reuteri supplementation. World J Gastroenterol. 2012;18:6250-6254. [PMID: 23180945 DOI: 10.3748/wjg.v18.i43.6250] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
58 Urrutia-Baca VH, Escamilla-García E, de la Garza-Ramos MA, Tamez-Guerra P, Gomez-Flores R, Urbina-Ríos CS. In Vitro Antimicrobial Activity and Downregulation of Virulence Gene Expression on Helicobacter pylori by Reuterin. Probiotics Antimicrob Proteins 2018;10:168-75. [PMID: 29103130 DOI: 10.1007/s12602-017-9342-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
59 Jarosz M, Rychlik E, Siuba M, Respondek W, Ryzko-Skiba M, Sajór I, Gugała S, Błazejczyk T, Ciok J. Dietary and socio-economic factors in relation to Helicobacter pylori re-infection. World J Gastroenterol 2009;15:1119-25. [PMID: 19266606 DOI: 10.3748/wjg.15.1119] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
60 Jones ML, Martoni CJ, Ganopolsky JG, Sulemankhil I, Ghali P, Prakash S. Improvement of gastrointestinal health status in subjects consuming Lactobacillus reuteri NCIMB 30242 capsules: a post-hoc analysis of a randomized controlled trial. Expert Opinion on Biological Therapy 2013;13:1643-51. [DOI: 10.1517/14712598.2013.833601] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
61 Losurdo G, Cubisino R, Barone M, Principi M, Leandro G, Ierardi E, Di Leo A. Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis. World J Gastroenterol. 2018;24:139-149. [PMID: 29358890 DOI: 10.3748/wjg.v24.i1.139] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 22] [Article Influence: 9.7] [Reference Citation Analysis]
62 Ren C, Faas MM, de Vos P. Disease managing capacities and mechanisms of host effects of lactic acid bacteria. Crit Rev Food Sci Nutr 2021;61:1365-93. [PMID: 32366110 DOI: 10.1080/10408398.2020.1758625] [Reference Citation Analysis]
63 Vitetta L, Briskey D, Hayes E, Shing C, Peake J. A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics. Inflammopharmacology. 2012;20:251-266. [PMID: 22427210 DOI: 10.1007/s10787-012-0126-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
64 Yang J, Zhou X, Liu X, Ling Z, Ji F. Role of the Gastric Microbiome in Gastric Cancer: From Carcinogenesis to Treatment. Front Microbiol 2021;12:641322. [PMID: 33790881 DOI: 10.3389/fmicb.2021.641322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
65 Dobrogosz WJ, Peacock TJ, Hassan HM. Evolution of the Probiotic Concept. Elsevier; 2010. pp. 1-41. [DOI: 10.1016/s0065-2164(10)72001-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
66 Brenner LA, Forster JE, Stearns-Yoder KA, Stamper CE, Hoisington AJ, Brostow DP, Mealer M, Wortzel HS, Postolache TT, Lowry CA. Evaluation of an Immunomodulatory Probiotic Intervention for Veterans With Co-occurring Mild Traumatic Brain Injury and Posttraumatic Stress Disorder: A Pilot Study. Front Neurol 2020;11:1015. [PMID: 33192959 DOI: 10.3389/fneur.2020.01015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
67 Aiba Y, Nakano Y, Koga Y, Takahashi K, Komatsu Y. A highly acid-resistant novel strain of Lactobacillus johnsonii No. 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin-mediated acid production in mice. Microbiologyopen. 2015;4:465-474. [PMID: 25771812 DOI: 10.1002/mbo3.252] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
68 Weiner N, Shaoul R. Impact of Age, Gender, and Addition of Probiotics on Treatment Success for Helicobacter pylori in Children. Glob Pediatr Health 2015;2:2333794X15607798. [PMID: 27335981 DOI: 10.1177/2333794X15607798] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]